Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting-Reference-Cited by-同舟云学术

Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting

Published:2018-10 Issue:17 Volume:72 Page:2086-2087
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Brener Sorin J.,Serruys Patrick W.,Morice Marie-Claude,Mehran Roxana,Kappetein Arie Pieter,Sabik Joseph F.,Liu Yangbo,Dressler Ovidiu,Ben-Yehuda Ori,Stone Gregg W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference4 articles.

1. Everolimus-eluting stents or bypass surgery for left main coronary artery disease;Stone;N Engl J Med,2016

2. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials;Palmerini;Lancet,2015

3. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

4. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Stenosis: 6 versus 12 Months;Journal of Clinical Medicine;2024-09-13

2. State-of-the-art percutaneous coronary intervention for left main coronary artery disease in Japan;Cardiovascular Intervention and Therapeutics;2024-07-30

3. Left Main Coronary Artery Disease: A Contemporary Review of Diagnosis and Management;Reviews in Cardiovascular Medicine;2024-02-18

4. Dual Antiplatelet Therapy Duration After Percutaneous Coronary Interventions of Left Main Coronary Artery Disease: A Meta-Analysis;The American Journal of Cardiology;2023-10

5. Revascularization in Left Main Coronary Artery Disease;Current Treatment Options in Cardiovascular Medicine;2023-05-18